Protection of primary cilia is an effective countermeasure against the impairment of osteoblast function induced by

Jing Liu1, Fei-Fan Leng2, Yu-Hai Gao1

  • 1Fundamental Medical Science Research Laboratories, The 940th Hospital of Joint Logistic Support Force, People's Liberation Army of China, Lanzhou, China.

Insights

Microgravity shortens osteoblast primary cilia, impairing bone formation by inhibiting BMP-2 signaling. Restoring miRNA-129-3p levels counteracts this, suggesting a potential therapy for spaceflight-induced bone loss.

Area of Science:

  • Cell Biology
  • Bone Biology
  • Space Biology

Background:

  • Microgravity's impact on bone formation is poorly understood, lacking specific preventative therapies.
  • Previous research showed microgravity shortens osteoblast primary cilia, reducing osteogenic potential.
  • Primary cilia are crucial for osteoblast function and mechanotransduction.

Purpose of the Study:

  • To elucidate the molecular mechanism of microgravity-induced bone loss.
  • To investigate the role of miRNA-129-3p in primary cilia regulation under microgravity.
  • To explore miRNA-129-3p as a potential therapeutic target for microgravity-induced bone loss.

Main Methods:

  • Simulated microgravity using a random positioning machine (RPM) on rat calvarial osteoblasts (ROBs).
  • Analysis of BMP-2/Smad1/5/8 signaling pathway proteins localization and expression.
  • Assessment of miRNA-129-3p expression and its functional role via overexpression.

Main Results:

  • Microgravity inhibited BMP-2/Smad1/5/8 signaling, with key proteins localized to primary cilia.
  • Primary cilia resorption under microgravity correlated with reduced signaling protein expression.
  • Microgravity decreased miRNA-129-3p expression, mimicking primary cilia length changes.
  • Overexpression of miRNA-129-3p rescued BMP-2 signaling and osteogenic differentiation.

Conclusions:

  • miRNA-129-3p plays a critical role in microgravity-induced primary cilia resorption in osteoblasts.
  • Restoring miRNA-129-3p levels can counteract microgravity-induced impairment of osteoblast function.
  • miRNA-129-3p replenishment is a promising therapeutic strategy against spaceflight-related bone loss.